nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—bronchus—esophageal cancer	0.0913	0.266	CbGeAlD
Icosapent ethyl—DGAT1—trachea—esophageal cancer	0.082	0.239	CbGeAlD
Icosapent ethyl—DGAT1—digestive system—esophageal cancer	0.0705	0.206	CbGeAlD
Icosapent ethyl—DGAT1—lung—esophageal cancer	0.0589	0.172	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—esophageal cancer	0.0403	0.117	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—CYP26A1—esophageal cancer	0.0339	0.214	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—CRABP1—esophageal cancer	0.0288	0.182	CbGpPWpGaD
Icosapent ethyl—Facial paralysis—Capecitabine—esophageal cancer	0.0158	0.0346	CcSEcCtD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS1—esophageal cancer	0.0152	0.356	CrCbGaD
Icosapent ethyl—VIIth nerve paralysis—Capecitabine—esophageal cancer	0.0122	0.0268	CcSEcCtD
Icosapent ethyl—Icosapent—PTGS1—esophageal cancer	0.0119	0.28	CrCbGaD
Icosapent ethyl—Generalised oedema—Cisplatin—esophageal cancer	0.0114	0.0251	CcSEcCtD
Icosapent ethyl—Proctalgia—Capecitabine—esophageal cancer	0.0107	0.0235	CcSEcCtD
Icosapent ethyl—Sudden death—Capecitabine—esophageal cancer	0.00981	0.0215	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—esophageal cancer	0.00917	0.0579	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—esophageal cancer	0.0087	0.204	CrCbGaD
Icosapent ethyl—Infection—Carboplatin—esophageal cancer	0.00823	0.018	CcSEcCtD
Icosapent ethyl—Intestinal obstruction—Capecitabine—esophageal cancer	0.00736	0.0161	CcSEcCtD
Icosapent ethyl—Sudden death—Methotrexate—esophageal cancer	0.0073	0.016	CcSEcCtD
Icosapent ethyl—Pain—Carboplatin—esophageal cancer	0.00708	0.0155	CcSEcCtD
Icosapent ethyl—Laryngitis—Capecitabine—esophageal cancer	0.00696	0.0153	CcSEcCtD
Icosapent ethyl—Icosapent—PTGS2—esophageal cancer	0.00683	0.16	CrCbGaD
Icosapent ethyl—Body temperature increased—Carboplatin—esophageal cancer	0.00655	0.0144	CcSEcCtD
Icosapent ethyl—Fungal infection—Capecitabine—esophageal cancer	0.0065	0.0142	CcSEcCtD
Icosapent ethyl—Fluid retention—Cisplatin—esophageal cancer	0.00646	0.0142	CcSEcCtD
Icosapent ethyl—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00624	0.0137	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00619	0.0391	CbGpPWpGaD
Icosapent ethyl—Polyp—Methotrexate—esophageal cancer	0.00614	0.0135	CcSEcCtD
Icosapent ethyl—Cyst—Methotrexate—esophageal cancer	0.00559	0.0123	CcSEcCtD
Icosapent ethyl—Cataract—Capecitabine—esophageal cancer	0.00527	0.0116	CcSEcCtD
Icosapent ethyl—Neck pain—Capecitabine—esophageal cancer	0.00508	0.0111	CcSEcCtD
Icosapent ethyl—Melaena—Capecitabine—esophageal cancer	0.0049	0.0107	CcSEcCtD
Icosapent ethyl—Fungal infection—Methotrexate—esophageal cancer	0.00484	0.0106	CcSEcCtD
Icosapent ethyl—Colitis—Capecitabine—esophageal cancer	0.00482	0.0106	CcSEcCtD
Icosapent ethyl—Fluid retention—Capecitabine—esophageal cancer	0.00476	0.0104	CcSEcCtD
Icosapent ethyl—Neoplasm—Capecitabine—esophageal cancer	0.00454	0.00995	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00445	0.00976	CcSEcCtD
Icosapent ethyl—Pancreatitis—Cisplatin—esophageal cancer	0.00419	0.00918	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00418	0.0264	CbGpPWpGaD
Icosapent ethyl—Gastroenteritis—Capecitabine—esophageal cancer	0.00411	0.00901	CcSEcCtD
Icosapent ethyl—Increased appetite—Capecitabine—esophageal cancer	0.00388	0.0085	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00375	0.00823	CcSEcCtD
Icosapent ethyl—Arthritis—Capecitabine—esophageal cancer	0.00375	0.00822	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Cisplatin—esophageal cancer	0.00373	0.00818	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00365	0.0231	CbGpPWpGaD
Icosapent ethyl—Melaena—Methotrexate—esophageal cancer	0.00365	0.008	CcSEcCtD
Icosapent ethyl—Migraine—Capecitabine—esophageal cancer	0.00359	0.00786	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Capecitabine—esophageal cancer	0.00346	0.00759	CcSEcCtD
Icosapent ethyl—Mood swings—Capecitabine—esophageal cancer	0.00345	0.00757	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	0.00341	0.0215	CbGpPWpGaD
Icosapent ethyl—Neoplasm—Methotrexate—esophageal cancer	0.00338	0.00741	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00328	0.00719	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—SLC52A3—esophageal cancer	0.00324	0.0205	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—BLVRB—esophageal cancer	0.00324	0.0205	CbGpPWpGaD
Icosapent ethyl—Gastritis—Capecitabine—esophageal cancer	0.00322	0.00707	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00321	0.00704	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Methotrexate—esophageal cancer	0.00318	0.00697	CcSEcCtD
Icosapent ethyl—Abdominal distension—Capecitabine—esophageal cancer	0.00317	0.00695	CcSEcCtD
Icosapent ethyl—Influenza—Capecitabine—esophageal cancer	0.00315	0.0069	CcSEcCtD
Icosapent ethyl—Asthma—Capecitabine—esophageal cancer	0.00315	0.0069	CcSEcCtD
Icosapent ethyl—Dysphagia—Capecitabine—esophageal cancer	0.00315	0.0069	CcSEcCtD
Icosapent ethyl—Angina pectoris—Capecitabine—esophageal cancer	0.00307	0.00672	CcSEcCtD
Icosapent ethyl—Arrhythmia—Cisplatin—esophageal cancer	0.00305	0.0067	CcSEcCtD
Icosapent ethyl—Bronchitis—Capecitabine—esophageal cancer	0.00303	0.00664	CcSEcCtD
Icosapent ethyl—Alopecia—Cisplatin—esophageal cancer	0.00302	0.00662	CcSEcCtD
Icosapent ethyl—Malnutrition—Cisplatin—esophageal cancer	0.00298	0.00653	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.0029	0.0183	CbGpPWpGaD
Icosapent ethyl—Hyperglycaemia—Capecitabine—esophageal cancer	0.00284	0.00623	CcSEcCtD
Icosapent ethyl—Pneumonia—Capecitabine—esophageal cancer	0.00282	0.00619	CcSEcCtD
Icosapent ethyl—Infestation—Capecitabine—esophageal cancer	0.00281	0.00615	CcSEcCtD
Icosapent ethyl—Infestation NOS—Capecitabine—esophageal cancer	0.00281	0.00615	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00277	0.00607	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Cisplatin—esophageal cancer	0.00276	0.00605	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CA1—esophageal cancer	0.00276	0.0174	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC10A2—esophageal cancer	0.00276	0.0174	CbGpPWpGaD
Icosapent ethyl—Myocardial infarction—Capecitabine—esophageal cancer	0.00275	0.00603	CcSEcCtD
Icosapent ethyl—Malaise—Cisplatin—esophageal cancer	0.00268	0.00588	CcSEcCtD
Icosapent ethyl—Epistaxis—Capecitabine—esophageal cancer	0.00265	0.00581	CcSEcCtD
Icosapent ethyl—Mood swings—Methotrexate—esophageal cancer	0.00257	0.00563	CcSEcCtD
Icosapent ethyl—Myalgia—Cisplatin—esophageal cancer	0.00253	0.00556	CcSEcCtD
Icosapent ethyl—Rhinitis—Capecitabine—esophageal cancer	0.00253	0.00554	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CA2—esophageal cancer	0.00252	0.0159	CbGpPWpGaD
Icosapent ethyl—Discomfort—Cisplatin—esophageal cancer	0.0025	0.00549	CcSEcCtD
Icosapent ethyl—Pharyngitis—Capecitabine—esophageal cancer	0.0025	0.00548	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00247	0.0156	CbGpPWpGaD
Icosapent ethyl—Oedema—Cisplatin—esophageal cancer	0.00243	0.00533	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Cisplatin—esophageal cancer	0.00243	0.00533	CcSEcCtD
Icosapent ethyl—Infection—Cisplatin—esophageal cancer	0.00241	0.00529	CcSEcCtD
Icosapent ethyl—Tachycardia—Cisplatin—esophageal cancer	0.00237	0.0052	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Cisplatin—esophageal cancer	0.00235	0.00515	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ADH7—esophageal cancer	0.00235	0.0148	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLCE1—esophageal cancer	0.00235	0.0148	CbGpPWpGaD
Icosapent ethyl—Asthma—Methotrexate—esophageal cancer	0.00234	0.00514	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.00232	0.0147	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00232	0.0146	CbGpPWpGaD
Icosapent ethyl—Anorexia—Cisplatin—esophageal cancer	0.00232	0.00508	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methotrexate—esophageal cancer	0.0023	0.00504	CcSEcCtD
Icosapent ethyl—Chills—Capecitabine—esophageal cancer	0.00226	0.00496	CcSEcCtD
Icosapent ethyl—Arrhythmia—Capecitabine—esophageal cancer	0.00225	0.00494	CcSEcCtD
Icosapent ethyl—Alopecia—Capecitabine—esophageal cancer	0.00223	0.00488	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00221	0.00485	CcSEcCtD
Icosapent ethyl—Malnutrition—Capecitabine—esophageal cancer	0.00219	0.00481	CcSEcCtD
Icosapent ethyl—Dyspnoea—Cisplatin—esophageal cancer	0.00217	0.00475	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—esophageal cancer	0.00216	0.00473	CcSEcCtD
Icosapent ethyl—Dysgeusia—Capecitabine—esophageal cancer	0.00215	0.00471	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CA—esophageal cancer	0.00212	0.0134	CbGpPWpGaD
Icosapent ethyl—Back pain—Capecitabine—esophageal cancer	0.00212	0.00465	CcSEcCtD
Icosapent ethyl—Decreased appetite—Cisplatin—esophageal cancer	0.00211	0.00463	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—esophageal cancer	0.0021	0.00461	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0021	0.0046	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—esophageal cancer	0.00209	0.00458	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—esophageal cancer	0.00209	0.00458	CcSEcCtD
Icosapent ethyl—Pain—Cisplatin—esophageal cancer	0.00208	0.00455	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ADH1B—esophageal cancer	0.00206	0.013	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Capecitabine—esophageal cancer	0.00204	0.00446	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—esophageal cancer	0.002	0.00439	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Cisplatin—esophageal cancer	0.002	0.00439	CcSEcCtD
Icosapent ethyl—Malaise—Capecitabine—esophageal cancer	0.00198	0.00434	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—esophageal cancer	0.00197	0.00432	CcSEcCtD
Icosapent ethyl—Vertigo—Capecitabine—esophageal cancer	0.00197	0.00432	CcSEcCtD
Icosapent ethyl—Syncope—Capecitabine—esophageal cancer	0.00197	0.00431	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—TYMP—esophageal cancer	0.00197	0.0124	CbGpPWpGaD
Icosapent ethyl—Loss of consciousness—Capecitabine—esophageal cancer	0.00193	0.00423	CcSEcCtD
Icosapent ethyl—Body temperature increased—Cisplatin—esophageal cancer	0.00192	0.00421	CcSEcCtD
Icosapent ethyl—Cough—Capecitabine—esophageal cancer	0.00191	0.0042	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYP26A1—esophageal cancer	0.00191	0.0121	CbGpPWpGaD
Icosapent ethyl—Hypertension—Capecitabine—esophageal cancer	0.00189	0.00415	CcSEcCtD
Icosapent ethyl—Arthralgia—Capecitabine—esophageal cancer	0.00187	0.00409	CcSEcCtD
Icosapent ethyl—Chest pain—Capecitabine—esophageal cancer	0.00187	0.00409	CcSEcCtD
Icosapent ethyl—Myalgia—Capecitabine—esophageal cancer	0.00187	0.00409	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ALOX15—esophageal cancer	0.00186	0.0118	CbGpPWpGaD
Icosapent ethyl—Pharyngitis—Methotrexate—esophageal cancer	0.00186	0.00408	CcSEcCtD
Icosapent ethyl—Discomfort—Capecitabine—esophageal cancer	0.00185	0.00405	CcSEcCtD
Icosapent ethyl—Dry mouth—Capecitabine—esophageal cancer	0.00183	0.004	CcSEcCtD
Icosapent ethyl—Oedema—Capecitabine—esophageal cancer	0.00179	0.00393	CcSEcCtD
Icosapent ethyl—Infection—Capecitabine—esophageal cancer	0.00178	0.0039	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—TPI1—esophageal cancer	0.00178	0.0112	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTO1—esophageal cancer	0.00178	0.0112	CbGpPWpGaD
Icosapent ethyl—Shock—Capecitabine—esophageal cancer	0.00176	0.00386	CcSEcCtD
Icosapent ethyl—Tachycardia—Capecitabine—esophageal cancer	0.00175	0.00383	CcSEcCtD
Icosapent ethyl—Asthenia—Cisplatin—esophageal cancer	0.00174	0.00382	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Capecitabine—esophageal cancer	0.00173	0.00379	CcSEcCtD
Icosapent ethyl—Anorexia—Capecitabine—esophageal cancer	0.00171	0.00374	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ALDOB—esophageal cancer	0.0017	0.0108	CbGpPWpGaD
Icosapent ethyl—Chills—Methotrexate—esophageal cancer	0.00168	0.00369	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—esophageal cancer	0.00166	0.00363	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GAPDH—esophageal cancer	0.00164	0.0104	CbGpPWpGaD
Icosapent ethyl—Malnutrition—Methotrexate—esophageal cancer	0.00163	0.00358	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00163	0.00358	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CRABP1—esophageal cancer	0.00163	0.0103	CbGpPWpGaD
Icosapent ethyl—Insomnia—Capecitabine—esophageal cancer	0.00162	0.00355	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—esophageal cancer	0.0016	0.00351	CcSEcCtD
Icosapent ethyl—Dyspnoea—Capecitabine—esophageal cancer	0.0016	0.0035	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—esophageal cancer	0.00158	0.00346	CcSEcCtD
Icosapent ethyl—Dyspepsia—Capecitabine—esophageal cancer	0.00158	0.00346	CcSEcCtD
Icosapent ethyl—Decreased appetite—Capecitabine—esophageal cancer	0.00156	0.00341	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GNG7—esophageal cancer	0.00155	0.00977	CbGpPWpGaD
Icosapent ethyl—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00155	0.00339	CcSEcCtD
Icosapent ethyl—Vomiting—Cisplatin—esophageal cancer	0.00154	0.00339	CcSEcCtD
Icosapent ethyl—Rash—Cisplatin—esophageal cancer	0.00153	0.00336	CcSEcCtD
Icosapent ethyl—Pain—Capecitabine—esophageal cancer	0.00153	0.00336	CcSEcCtD
Icosapent ethyl—Constipation—Capecitabine—esophageal cancer	0.00153	0.00336	CcSEcCtD
Icosapent ethyl—Dermatitis—Cisplatin—esophageal cancer	0.00153	0.00335	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—esophageal cancer	0.00152	0.00332	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Capecitabine—esophageal cancer	0.00148	0.00323	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—esophageal cancer	0.00147	0.00323	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—esophageal cancer	0.00147	0.00322	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ALDH2—esophageal cancer	0.00145	0.00915	CbGpPWpGaD
Icosapent ethyl—Cough—Methotrexate—esophageal cancer	0.00142	0.00312	CcSEcCtD
Icosapent ethyl—Body temperature increased—Capecitabine—esophageal cancer	0.00142	0.0031	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—esophageal cancer	0.00139	0.00305	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—esophageal cancer	0.00139	0.00305	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—esophageal cancer	0.00139	0.00305	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GSTT1—esophageal cancer	0.00138	0.00871	CbGpPWpGaD
Icosapent ethyl—Discomfort—Methotrexate—esophageal cancer	0.00137	0.00301	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYP2A6—esophageal cancer	0.00136	0.00861	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00136	0.00857	CbGpPWpGaD
Icosapent ethyl—Anaphylactic shock—Methotrexate—esophageal cancer	0.00133	0.00292	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—esophageal cancer	0.00132	0.0029	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTGS1—esophageal cancer	0.00129	0.00816	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ENO1—esophageal cancer	0.00129	0.00816	CbGpPWpGaD
Icosapent ethyl—Hyperhidrosis—Methotrexate—esophageal cancer	0.00129	0.00283	CcSEcCtD
Icosapent ethyl—Asthenia—Capecitabine—esophageal cancer	0.00128	0.00282	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PSME1—esophageal cancer	0.00127	0.00804	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PSME2—esophageal cancer	0.00127	0.00804	CbGpPWpGaD
Icosapent ethyl—Anorexia—Methotrexate—esophageal cancer	0.00127	0.00279	CcSEcCtD
Icosapent ethyl—Pruritus—Capecitabine—esophageal cancer	0.00127	0.00278	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00121	0.00266	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—esophageal cancer	0.00121	0.00264	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—esophageal cancer	0.00119	0.00261	CcSEcCtD
Icosapent ethyl—Dizziness—Capecitabine—esophageal cancer	0.00118	0.0026	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—esophageal cancer	0.00117	0.00257	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—esophageal cancer	0.00116	0.00254	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00115	0.00252	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—esophageal cancer	0.00114	0.0025	CcSEcCtD
Icosapent ethyl—Vomiting—Capecitabine—esophageal cancer	0.00114	0.0025	CcSEcCtD
Icosapent ethyl—Rash—Capecitabine—esophageal cancer	0.00113	0.00248	CcSEcCtD
Icosapent ethyl—Dermatitis—Capecitabine—esophageal cancer	0.00113	0.00247	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.00111	0.00702	CbGpPWpGaD
Icosapent ethyl—Feeling abnormal—Methotrexate—esophageal cancer	0.0011	0.00241	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYP1B1—esophageal cancer	0.0011	0.00694	CbGpPWpGaD
Icosapent ethyl—Body temperature increased—Methotrexate—esophageal cancer	0.00105	0.00231	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYP19A1—esophageal cancer	0.00103	0.00652	CbGpPWpGaD
Icosapent ethyl—Asthenia—Methotrexate—esophageal cancer	0.000956	0.0021	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—esophageal cancer	0.000943	0.00207	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—HMOX1—esophageal cancer	0.000942	0.00595	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000924	0.00584	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCB1—esophageal cancer	0.000904	0.00571	CbGpPWpGaD
Icosapent ethyl—Dizziness—Methotrexate—esophageal cancer	0.000881	0.00193	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—esophageal cancer	0.000847	0.00186	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—esophageal cancer	0.00084	0.00184	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—esophageal cancer	0.00084	0.00184	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000684	0.00432	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CREBBP—esophageal cancer	0.000604	0.00382	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NOS3—esophageal cancer	0.000541	0.00342	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—esophageal cancer	0.000495	0.00313	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—EP300—esophageal cancer	0.000412	0.0026	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CA—esophageal cancer	0.000304	0.00192	CbGpPWpGaD
